دورية أكاديمية
P-76 A phase 1 study of AMG 199, a half-life extended bispecific T-cell engager (HLE BiTE®) immune therapy, targeting MUC17 in patients with gastric and gastroesophageal junction cancer
| العنوان: | P-76 A phase 1 study of AMG 199, a half-life extended bispecific T-cell engager (HLE BiTE®) immune therapy, targeting MUC17 in patients with gastric and gastroesophageal junction cancer |
|---|---|
| المؤلفون: | Lordick, F., Orra, E. Buxó, Cervantes, A., Dayyani, F., Rocha-Lima, C., Greil, R., Laarhoven, H. van, Lorenzen, S., Kischel, R., Shitara, K., Chao, J. |
| المصدر: | In Annals of Oncology July 2020 31 Supplement 3:S114-S114 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2020.04.158 |